Dialysis Weaning in Intensive Care Units (Dialysis STOP)
D-STOP
Daily Urinary Urea Excretion to Guide Renal Replacement Therapy Weaning in Intensive Care Units
1 other identifier
observational
260
1 country
1
Brief Summary
Evaluation of daily urinary urea excretion, to guide Renal Replacement Therapy weaning, in Intensive Care Units. The objective is to show that remove the dialysis catheter, once daily urinary urea excretion is greater than 1.35 mmol/kg/d, would increase more than 3 days the number without dialysis catheters, and thus without dialysis, the first 28 days after insertion. Daily urinary urea excretion = urea (mmol/L) x diuresis (L/d) / weight (kg).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 29, 2018
CompletedFirst Posted
Study publicly available on registry
December 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedMarch 17, 2020
March 1, 2020
3 years
November 29, 2018
March 15, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
the catheter free days
days
the first 28 days after catheter insertion
Secondary Outcomes (8)
new dialysis catheter and new renal replacement therapy
the first 7 days after dialysis catheter ablation
number of dialysis catheter laid per patients
the first 28 days after catheter insertion
Duration of renal replacement therapy
the first 28 days after catheter insertion
Renal therapy replacement complications (hemorrhage, heparin-induced thrombocytopenia, other)
the first 28 days after catheter insertion
Dialysis catheters infections
the first 28 days after catheter insertion
- +3 more secondary outcomes
Study Arms (2)
the group BEFORE
Retrospective group. The daily urinary urea excretion was unknown.
the group AFTER
Prospective group. Use the daily urinary urea excretion to guide the renal replacement therapy weaning.
Interventions
Eligibility Criteria
All patients \> 18 years of age, admitted to intensive care unit, who have a RRT for AKI.
You may qualify if:
- All patients \> 18 of age, who have a Renal Replacement Therapy, in intensive care unit,
- with a diuresis \> 100 ml/d.
You may not qualify if:
- Patients still presenting "hard" criteria for RRT: metabolic acidosis with pH \< 7.15 and PCO2 \<50mmHg; acute pulmonary edema (\> 5l 02 or 50% FiO2 for Sp02 \> 95%) objectified by echocardiography; K\> 5.5 mmol/l after treatment
- Renal transplantation
- Long-term chronic kidney injury or short-term dialysis project (arteriovenous fistula created).
- Acute Kidney Injury secondary to thrombotic microangiopathy
- Acute Kidney Injury secondary to an obstacle even if dialysed
- RRT started for toxic cause without IRA (lithium,...)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandre Gros
Bordeaux, Aquitaine, 33000, France
Related Publications (2)
Aniort J, Ait Hssain A, Pereira B, Coupez E, Pioche PA, Leroy C, Heng AE, Souweine B, Lautrette A. Daily urinary urea excretion to guide intermittent hemodialysis weaning in critically ill patients. Crit Care. 2016 Feb 19;20:43. doi: 10.1186/s13054-016-1225-5.
PMID: 26895760BACKGROUNDBodot S, Gros A, Le Gall L, Martin A, Gisbert-Mora C, Pillot J, Ragot C, Grand H, Romen A, Masri A, Dewitte A, Gruson D, Prevel R, Rubin S, Orieux A, Boyer A. Effects of the urinary urea excretion index on the decision to wean ICU patients with acute kidney injury from renal replacement therapy: a before-after multicentre study (D-STOP). Crit Care. 2025 Jul 1;29(1):261. doi: 10.1186/s13054-025-05289-8.
PMID: 40598590DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDIV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- GROS, Alexandre, Medical Doctor, Intensive Care Unit, Principal Investigator
Study Record Dates
First Submitted
November 29, 2018
First Posted
December 4, 2018
Study Start
September 1, 2016
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
March 17, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share